Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 9, 2006

Primary Completion Date

March 10, 2010

Study Completion Date

March 10, 2010

Conditions
Pulmonary Hypertension
Interventions
DRUG

Nitric Oxide/INP Pulse Delivery

DRUG

Nitric Oxide/INO Pulse Delivery

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00352430 - Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension | Biotech Hunter | Biotech Hunter